Skip to content
Screener

Johnson & Johnson JNJ Q2 2025 earnings

Reported July 16, 2025 · Before market open

Revenue$23.7BBeat by $889.0M
EPS$2.77Beat by $0.09
Revenue estimate$22.9B
EPS estimate$2.68

Next report

Oct 13, 2026 (In 1 week)
Revenue estimate$25.4B
EPS estimate$2.78

Financials

Q2 2025

Income statement

See full
Revenue$23.7B+5.8%
Gross profit$16.1B+3.4%
Operating income$6.6B+5.9%
Net income$5.5B+18.2%
EPS (diluted)$2.29+18.7%

Balance sheet

See full
Cash & equivalents$18.6B-25.3%
Total debt$50.8B+22.3%
Total equity$78.5B+9.7%
Total assets$193.39B+6.8%

Cash flow

See full
Operating cash flow$3.9B-31.2%
CapEx$1.0B+6.9%
Free cash flow$2.8B-39.1%

Valuation & ratios

Valuation

as of 06/29/25
See full
Market cap$366.18B+4.1%
Enterprise value$398.36B+8.1%
P/E16.2×+6.9×
P/S4×0.0×

Profitability

See full
Gross margin67.9%-1.1pp
Operating margin23.7%-2.4pp
Net margin25%-18.9pp
FCF margin20.5%-3.0pp

Returns & leverage

See full
Return on equity30.2%-21.6pp
Debt / equity0.6×+0.1×
Current ratio1×-0.1×

Segments

By product

See full
DARZALEX$3.5B+23.0%
Other$2.8B+833%
STELARA$1.7B-42.7%
GENERAL$1.4B+3.3%
Tremfya$1.2B+30.9%

By geography

See full
Europe$5.4B+3.3%
Asia-Pacific, Africa$3.6B+4.5%
Western Hemisphere, excluding U.S.$1.2B-0.5%

By segment

See full
Innovative Medicine$15.2B+4.9%
MEDTECH$8.5B+7.3%

FAQ

When did Johnson & Johnson report Q2 2025 earnings?
Johnson & Johnson (JNJ) reported Q2 2025 earnings on July 16, 2025 before market open.
What were Johnson & Johnson's Q2 2025 revenue and EPS?
Johnson & Johnson reported revenue of $23.7B and eps of $2.77 for Q2 2025.
Did Johnson & Johnson beat estimates in Q2 2025?
Revenue beat the consensus estimate of $22.9B by $889.0M. EPS beat the consensus estimate of $2.68 by $0.09.
How did Johnson & Johnson's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.8% from $22.4B a year earlier and eps declined 1.8% from $2.82.
Where can I find Johnson & Johnson's Q2 2025 SEC filings?
You can read the 8-K earnings release (0000200406-25-000170) and the 10-Q periodic report (0000200406-25-000178) directly on SEC EDGAR. The filing index links above go to sec.gov.